More thoughts on young blood, from Derek Lowe.
Category Archives: Science And Society
Soylent
A New Yorker reporter gives it a try.
I haven’t read the whole thing yet.
[A while later]
OK, I did read it. I was amused to learn that he was hawking it at my own local Whole Foods. One concern I have is his use of seed oils. Canola has too much omega 6 for my health. I’d use olive instead, though it costs more. If you don’t use virgin, though, it doesn’t have to cost that much.
Apollo And The Pyramids
An analysis from Randall Munroe.
An Anti-Aging Hormone
…that could make you smarter?
Heck, I’d be happy with the anti-aging part myself. Though I have a commenter or two that could stand to be smarter.
The Climate Debate Is Over
…and the alarmists lost.
[Update a while later]
Why is Obama getting a pass on his climate lies?
Really, at this point, why does anyone believe anything he says any more?
Heartburn
Apparently, carb reduction can help with GERDS.
The National Climate “Assessment”
Judith Curry has the goods on this latest bout of junk science:
My main conclusion from reading the report is this: the phrase ‘climate change’ is now officially meaningless. The report effectively implies that there is no climate change other than what is caused by humans, and that extreme weather events are equivalent to climate change. Any increase in adverse impacts from extreme weather events or sea level rise is caused by humans. Possible scenarios of future climate change depend only on emissions scenarios that are translated into warming by climate models that produce far more warming than has recently been observed.
Roger Pielke approves.
Cancer
Have they really found a cure?
…the developments at Penn point, tantalizingly, to something more, something that would rank among the great milestones in the history of mankind: a true cure. Of 25 children and 5 adults with Emily’s disease, ALL, 27 had a complete remission, in which cancer becomes undetectable.“
It’s a stunning breakthrough,” says Sally Church, of drug development advisor Icarus Consultants. Says Crystal Mackall, who is developing similar treatments at the National Cancer Institute: “It really is a revolution. This is going to open the door for all sorts of cell-based and gene therapy for all kinds of disease because it’s going to demonstrate that it’s economically viable.”
Also:
“I’ve told the team that resources are not an issue. Speed is the issue,” says Novartis Chief Executive Joseph Jimenez, 54. “I want to hear what it takes to run this phase III trial and to get this to market. You’re talking about patients who are about to die. The pain of having to turn patients away is such that we are going as fast as we can and not letting resources get in the way.”
Yes. Faster please.
Last Week’s Ruling
In his inimitable way, Mark Steyn explains:
The way the DC “legislature” wrote the Anti-SLAPP law it’s unclear whether a denial of an anti-SLAPP motion is appealable. So my co-defendants would like the Court of Appeals to rule on the question. They could have ruled on it way back last autumn when the denial of the motion to dismiss the original complaint was appealed, but by then Michael E Mann, whose original complaint was as poorly constructed as his hockey stick, had filed his amended complaint, so the Court of Appeals ruled that it was moot. If you’re wondering what “it” is in that last clause, “it” is any combination of: a) the original complaint; b) the original motion to dismiss the original complaint; c) the original denial of the original motion to dismiss the original complaint; d) the original appeal of the original denial of the original motion to dismiss the original complaint; e) the original appeal of whether the original appeal of the original denial of the original motion to dismiss the original complaint is appealable; or f) a gluten-free chia-seed bagel three days past its sell-by date left under the judges’ desk.
Or something.
Aspirin
I’ve been taking an 81 mg dose for heart-attack/stroke prevention, but maybe I shouldn’t be.
And how did they come up with 81 for the dosage? Why not a round number?